Cargando…
Diffuse midline glioma treated with epigenetic agent-based immunotherapy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852273/ https://www.ncbi.nlm.nih.gov/pubmed/36658142 http://dx.doi.org/10.1038/s41392-022-01274-7 |
| _version_ | 1784872580995350528 |
|---|---|
| author | Jing, Linkai Qian, Zhihong Gao, Qiang Sun, Rui Zhen, Zili Wang, Guihuai Yang, Xuejun Li, Haitao Guo, Tiannan Zhang, Wei |
| author_facet | Jing, Linkai Qian, Zhihong Gao, Qiang Sun, Rui Zhen, Zili Wang, Guihuai Yang, Xuejun Li, Haitao Guo, Tiannan Zhang, Wei |
| author_sort | Jing, Linkai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9852273 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98522732023-01-21 Diffuse midline glioma treated with epigenetic agent-based immunotherapy Jing, Linkai Qian, Zhihong Gao, Qiang Sun, Rui Zhen, Zili Wang, Guihuai Yang, Xuejun Li, Haitao Guo, Tiannan Zhang, Wei Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-01-20 /pmc/articles/PMC9852273/ /pubmed/36658142 http://dx.doi.org/10.1038/s41392-022-01274-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Jing, Linkai Qian, Zhihong Gao, Qiang Sun, Rui Zhen, Zili Wang, Guihuai Yang, Xuejun Li, Haitao Guo, Tiannan Zhang, Wei Diffuse midline glioma treated with epigenetic agent-based immunotherapy |
| title | Diffuse midline glioma treated with epigenetic agent-based immunotherapy |
| title_full | Diffuse midline glioma treated with epigenetic agent-based immunotherapy |
| title_fullStr | Diffuse midline glioma treated with epigenetic agent-based immunotherapy |
| title_full_unstemmed | Diffuse midline glioma treated with epigenetic agent-based immunotherapy |
| title_short | Diffuse midline glioma treated with epigenetic agent-based immunotherapy |
| title_sort | diffuse midline glioma treated with epigenetic agent-based immunotherapy |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852273/ https://www.ncbi.nlm.nih.gov/pubmed/36658142 http://dx.doi.org/10.1038/s41392-022-01274-7 |
| work_keys_str_mv | AT jinglinkai diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy AT qianzhihong diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy AT gaoqiang diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy AT sunrui diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy AT zhenzili diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy AT wangguihuai diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy AT yangxuejun diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy AT lihaitao diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy AT guotiannan diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy AT zhangwei diffusemidlinegliomatreatedwithepigeneticagentbasedimmunotherapy |